+Search query
-Structure paper
Title | Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism. |
---|---|
Journal, issue, pages | Plos One, Vol. 11, Page e0157509-e0157509, Year 2016 |
Publish date | Jun 3, 2016 (structure data deposition date) |
Authors | Grimshaw, C.E. / Jennings, A. / Kamran, R. / Ueno, H. / Nishigaki, N. / Kosaka, T. / Tani, A. / Sano, H. / Kinugawa, Y. / Koumura, E. ...Grimshaw, C.E. / Jennings, A. / Kamran, R. / Ueno, H. / Nishigaki, N. / Kosaka, T. / Tani, A. / Sano, H. / Kinugawa, Y. / Koumura, E. / Shi, L. / Takeuchi, K. |
External links | Plos One / PubMed:27328054 |
Methods | X-ray diffraction |
Resolution | 2.24 Å |
Structure data | PDB-5kby: |
Chemicals | ChemComp-NAG: ChemComp-6RL: ChemComp-HOH: |
Source |
|
Keywords | HYDROLASE/HYDROLASE INHIBITOR / peptidase / glp-1 / metabolic disease / co-complex / HYDROLASE-HYDROLASE INHIBITOR complex |